• Email Us: [email protected]
  • Contact Us: +1 718 874 1545
  • Skip to main content
  • Skip to primary sidebar

Medical Market Report

  • Home
  • All Reports
  • About Us
  • Contact Us

Gene Therapy Partly Restores Cone Receptors In Eyes Of Children Born Color Blind

August 23, 2022 by Deborah Bloomfield

Experimental gene therapy has partly restored the function of the retina’s cone receptors in two children who were born totally colorblind, according to a new study reported in the journal Brain.

Not only have the two patients reported “changes” to their vision, but brain imaging also showed that the researchers were able to reawaken dormant neural circuits and evoke visual signals that had never been experienced by these young people.

The breakthrough comes from two trials testing gene therapies targeting specific genes known to be linked to achromatopsia, a genetic condition also known as total color blindness.

This disease is caused by variants of the genes related to cone cells, one of the two types of photoreceptors within our eye’s retina that are responsible for color vision. Along with not being able to perceive any color, people with achromatopsia also experience generally poor vision and find bright light uncomfortable. 

While previously gene therapies for color blindness have shown hope, there has been some uncertainty about whether dormant cone-signaling pathways in the brain and visual system of people with achromatopsia can be reawakened after years of deprivation.

Advertisement

The answer is yes, according to this new study – providing huge hope for this potentially life-changing gene therapy. 

“Our study is the first to directly confirm widespread speculation that gene therapy offered to children and adolescents can successfully activate the dormant cone photoreceptor pathways and evoke visual signals never previously experienced by these patients,” Dr Tessa Dekker, lead study author from UCL Institute of Ophthalmology, said in a statement sent to IFLScience.

In the new study, UCL researchers used fMRI brain scans to study four children who had received the gene therapy, then compared them to nine untreated patients and 28 volunteers with normal vision.

Advertisement

In two of the four treated children, the imaging showed strong evidence for cone-mediated signals in the brain’s visual cortex coming from the treated eye. Prior to the treatment, there was no evidence of cone function, but now the pair showed neural activity that closely resembled those of the normal-sighted people. 

The team says this feat may only be possible in young people due to the plasticity of their brain and its remarkable ability to adapt. 

“We are demonstrating the potential of leveraging the plasticity of our brains, which may be particularly able to adapt to treatment effects when people are young,” added Dr Dekker. 

Advertisement

The question now is: has the therapy actually gifted the children with color vision? The researchers asked the two patients to complete a psychophysical test of cone function, which showed notable changes in the way the children perceived different levels of contrast. 

One of the patients commented: “Seeing changes to my vision has been very exciting, so I’m keen to see if there are any more changes and where this treatment as a whole might lead in the future.”

The researchers are keen to back up their findings with further research, but it’s currently looking pretty promising. 

Advertisement

“We are still analyzing the results from our two clinical trials, to see whether this gene therapy can effectively improve everyday vision for people with achromatopsia,” said Dr Michel Michaelides, co-lead author from the UCL Institute of Ophthalmology and Moorfields Eye Hospital.

“We hope that with positive results, and with further clinical trials, we could greatly improve the sight of people with inherited retinal diseases.” 

Deborah Bloomfield
Deborah Bloomfield

Related posts:

  1. Apple’s new MagSafe wallet can be located with the ‘Find My’ app if it goes missing
  2. Report: NBA won’t mandate vaccine for players
  3. Soccer-Real, Barca influence on Spain fades along with club superpower status
  4. Appsmith raises $8M to take on the internal corporate app market with open source code

Source Link: Gene Therapy Partly Restores Cone Receptors In Eyes Of Children Born Color Blind

Filed Under: News

Primary Sidebar

  • DNA From Greenland Sled Dogs – Maybe The World’s Oldest Breed – Reveals 1,000 Years Of Arctic History
  • Why Doesn’t Moonrise Shift By The Same Amount Each Night?
  • Moa De-Extinction, Fashionable Chimps, And Robot Surgery – No Human Required
  • “Human”: Powerful New Images Mark The Most Scientifically Accurate “Hyper-Real 3D Models Of Human Species Ever”
  • Did We Accidentally Leave Life On The Moon In 2019 – And Could We Revive It?
  • 1.8 Million Years Ago, Two Extinct Humans Had One Of The Gnarliest Deaths In History
  • “Powerful Image” Of One Of The World’s Rarest Tigers Exposes The Real Danger In Taman Negara
  • Evolution, Domestication, And A Lot Of Very Good Boys: How Wolves Became Dogs
  • Why Do Orcas Have White Spots Near Their Eyes?
  • Tomb Of First King Of Ancient Maya City Discovered In Belize
  • The Real Reason The Tip Of Your Tape Measure Wiggles Like That
  • The “Haunting” Last Message From NASA’s Opportunity Rover, Sent From Inside A Planet-Wide Storm
  • Adorable Video Proves Not All Gorillas Hate The Rain. It Might Even Win One A Mate
  • 5,000-Year-Old Rock Art May Show One Of Ancient Egypt’s First Rulers
  • Alzheimer’s-Linked Protein Levels “20 Times Higher” In Newborn Babies – What Does This Mean?
  • Americans Were Asked If They Thought Civil War Was Coming. The Results Were Unexpected
  • Voyager 1 & 2 Could Be Detected From Almost A Light-Year Away With Our Current Technology
  • Dams Have Nudged Earth’s Poles By Over 1 Meter In The Past 200 Years
  • This Sugar Could Be A Cure For Male Pattern Baldness – And It’s Been In Our Bodies All Along
  • “Cosmic Immigrants”: Daytime Star Seen In 1604 May Be An “Alien Type Ia Supernova”
  • Business
  • Health
  • News
  • Science
  • Technology
  • +1 718 874 1545
  • +91 78878 22626
  • [email protected]
Office Address
Prudour Pvt. Ltd. 420 Lexington Avenue Suite 300 New York City, NY 10170.

Powered by Prudour Network

Copyrights © 2025 · Medical Market Report. All Rights Reserved.

Go to mobile version